Interim clinical findings showed S4V was safe in all age groups. The Food and Drug Administration (FDA) has granted Fast Track designation to Shigella4V for the prevention of shigellosis. Considered a ...

Thanks to modern therapies, a cancer diagnosis is no longer an automatic death sentence. But many patients still suffer from unwanted side effects and limited efficacy. In a recent Bioconjugate ...

Piramal Pharma Solutions has joined forces with IntoCell to broaden its bioconjugates offering and support innovation in the field. Leveraging IntoCell's proprietary drug-linker technologies alongside ...

Often undetected until it has progressed to an advanced stage, pancreatic ductal adenocarcinoma (PDAC) is a lethal cancer. The K-Ras mutant pancreatic cancer is one of the most common types. At ...

Klebsiella pneumonia is a rare, life-threatening bacterial infection, which has become increasingly prevalent in many countries. New research suggests that there may be new promises for a bioconjugate ...

WuXi Biologics and WuXi STA have established a joint venture company named WuXi XDC to provide contract development and manufacturing of bioconjugates, including antibody-drug conjugates. WuXi ...

BOSTON & ST. LOUIS--(BUSINESS WIRE)--Omniose, a company developing polysaccharide conjugate vaccines against serious bacterial threats, announced today the expansion of the leadership team to include ...

CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary ...

WASHINGTON, Dec. 8, 2022 – The Publications Division of the American Chemical Society (ACS) has appointed Theresa Reineke, Ph.D., of the University of Minnesota, Twin Cities (UMTC), as editor in chief ...

Xiaoyuan (Shawn) Chen, senior investigator and chief of the Laboratory of Molecular Imaging and Nanomedicine at the National Institute of Biomedical Imaging & Bioengineering, is the 2016 recipient of ...